Higher mammography screening costs without appreciable clinical benefit: the case of digital mammography. Read more about Higher mammography screening costs without appreciable clinical benefit: the case of digital mammography.
Changes in breast cancer risk distribution among Vermont women using screening mammography. Read more about Changes in breast cancer risk distribution among Vermont women using screening mammography.
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. Read more about Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.
Mammographic density phenotypes and risk of breast cancer: a meta-analysis. Read more about Mammographic density phenotypes and risk of breast cancer: a meta-analysis.
Pleiotropic associations of risk variants identified for other cancers with lung cancer risk: the PAGE and TRICL consortia. Read more about Pleiotropic associations of risk variants identified for other cancers with lung cancer risk: the PAGE and TRICL consortia.
Challenges and possible solutions to colorectal cancer screening for the underserved. Read more about Challenges and possible solutions to colorectal cancer screening for the underserved.
Investigation of mammographic breast density as a risk factor for ovarian cancer. Read more about Investigation of mammographic breast density as a risk factor for ovarian cancer.
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG. Read more about Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy. Read more about Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy.
Risk factors for inflammatory breast cancer and other invasive breast cancers. Read more about Risk factors for inflammatory breast cancer and other invasive breast cancers.
